House Committee Faults NIH Director On Lax Conflict Of Interest Policies At The Agency
This article was originally published in The Pink Sheet Daily
Executive Summary
Rep. Greenwood plans to obtain information directly from pharmaceutical companies regarding financial arrangements with senior NIH officials. The committee will hold a follow-up hearing May 18.
You may also be interested in...
NIH Policies On Outside Compensation Should Be More Restrictive, Former Director Says
Memorial Sloan-Kettering Cancer Center President Harold Varmus tells House subcommittee that clearer NIH rules are needed but cautions against a blanket restriction on outside activities.
NIH Policies On Outside Compensation Should Be More Restrictive, Former Director Says
Memorial Sloan-Kettering Cancer Center President Harold Varmus tells House subcommittee that clearer NIH rules are needed but cautions against a blanket restriction on outside activities.
FDA Employees’ Outside Activities Will Receive Scrutiny By Center Directors
Activities had been approved at lower levels, but the interim policy – issued following questions about behavior of NIH scientists – escalates the oversight. All outside activities by FDA employees will be reviewed as part of the development of a final policy.